BioPharm Solutions (BPS), Inc. is a New Jersey-headquartered drug delivery company dedicated to developing novel dosage forms and their manufacturing processes for biologic medicines, including proteins, peptides, and RNA. Our proprietary platform technologies include:
-
Microsphere Production: The BPS R&D team has upgraded the microsphere production process into a continuous, protein-compatible system featuring closed-loop solvent recycling, capable of producing uniform microspheres.
-
3D Printed Microneedles: The team has engineered a rapid, mold-free 3D printing system capable of simultaneously producing microneedle patches featuring hundreds of digitally designed needle tips.
-
RNA Delivery Vectors: For RNA delivery, the scientists on the team synthesized a non-cytotoxic cationic polymeric vector composed of and degrading into endogenous monomers, enabling rapid endosomal escape and RNA release via pH-responsive degradation.
BPS is currently seeking partners developing commercial pharmaceutical dosage forms to leverage and license these proprietary technologies. We specialize earlier-stage innovation and empower our licensees through comprehensive support including contracted R&D and technical training.
.
|
